Skip to search formSkip to main contentSkip to account menu

UCB 35625

Known as: J113863, J 113863, UCB35625 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
A growing body of evidence has indicated that the release of nociceptive factors, such as interleukins and chemokines, by… 
2016
2016
Chemokines are chemotactic cytokines whose involvement in nociceptive processing is being increasingly recognized. Based on the… 
2016
2016
Biased agonism at G protein-coupled receptors constitutes a promising area of research for the identification of new therapeutic… 
Highly Cited
2007
Highly Cited
2007
Chemokine receptor CCR3 is highly expressed by eosinophils and signals in response to binding of the eotaxin family of chemokines… 
Highly Cited
2006
Highly Cited
2006
The chemokine receptor CCR1 is a potential target for the treatment of rheumatoid arthritis. To explore the impact of CCR1… 
Highly Cited
2004
Highly Cited
2004
Interactions between proinflammatory and cell maturation signals, and the pathways that regulate leukocyte migration, are of… 
Highly Cited
2000
Highly Cited
2000
We describe a small molecule chemokine receptor antagonist, UCB35625 (the trans-isomer J113863 published by Banyu Pharmaceutical…